Quantcast

Silver State Times

Wednesday, April 23, 2025

Nevada: Biologics companies were the least FDA inspected companies in Nevada in Q1

Webp 2ezm6a5laa3vullezt9gk0ym96qi

Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website

Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website

In the first quarter of 2025, one Biologics company received an FDA inspection in Nevada, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in Nevada, equalling 25% of all inspections in the first quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Nevada During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1
Food Composition, Standards, Labeling and Econ2
Foodborne Biological Hazards1

MORE NEWS